AstraZeneca COVID-19 vaccine: EMA continues review of rare blood clots News item 10 April 2021 Pages: 2 - 2
FDA warning companies not to sell unapproved cannabidiol products News item 10 April 2021 Pages: 5 - 5
Anti-PD1-based immunotherapy: risk of delayed immune-related AEs Clinical study 10 April 2021 Pages: 7 - 7